ADC Therapeutics is stepping away from a solid tumor pact with Adagene rather than take the collaboration to the next stage. Details were sparse in Adagene’s Thursday update, which said only ...

LAUSANNE, Switzerland, April 28, 2025 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today ...